CRC Genetic Mutation Screening Kit, developed by GenoBio Biotechnology, is designed to support personalized cancer treatment. Its special LNA-based design offers a highly sensitive approach for detection of low amounts of cfDNA by semi-invasive or non-invasive methods. This kit is compatible with qPCR devices used in most hospital laboratories and provides a fast and economical solution by minimizing laboratory requirements.

The development of the CRC Genetic Mutation Screening Kit is approaching its final stages. Keep visiting our website to follow updates and progress.